-
FDA stops the review of the incomplete data (two-dose COVID vaccine for children 0-5 years-old) it asked from Pfizer. Why did you ask for it in the first place? Says now it will wait for the complete three-dose data set. What a surprise.????
Medical Mythbusting Commentary for February 14, 2022 Source:In reversal, FDA puts brakes on COVID shots for kids under 5
-
Wait times for cancer drug approval in Canada double that of the US and Europe
Madely Health Headlines Commentary for July 26, 2012 [display_podcast] Source: The Fraser Institute: Canadians Wait Almost Twice as Long as Americans for New, Life-Saving Cancer Drugs
-
Cost vs. benefit: The approval of new anti-cancer therapies
Original broadcast date: July 19, 2009 In a recent issue of the Journal of the National Cancer Institute, Drs. Tito Fojo of the National Cancer Institute’s medical oncology division and Christine Grady of the NIH’s bioethics department recommended that studies of cancer drugs that provide two months or less of extended survival should be undertaken…
-
Access Delayed, Access Denied 2007 report
A caller to Sunday House Call recently enquired about the drug approval process and why there seems to be certain medications available in other countries but not in Canada? According to a report entitled Access Delayed, Access Denied published by The Fraser Institute, Brett Skinner, Director, Health, Pharmaceutical and Insurance Policy Research states that “the…
-
The Misguided War Against Medicines
What proportion of our health care costs does each sector of our health care system consume and what are their growth rates? This answer to question is germane to governments facing serious health care budgetary constraints. There is an argument put forward that hospitals and prescription medication costs are the principle contributors to a system…